57 related articles for article (PubMed ID: 23422504)
1. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
Lee JY; Myung SK; Song YS
Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
[TBL] [Abstract][Full Text] [Related]
2. Self-assembly nanoplatform of platinum (Ⅳ) prodrug for enhanced ovarian cancer therapy.
Ma X; Liu Y; Wu H; Tan J; Yi W; Wang Z; Yu Z; Wang X
Mater Today Bio; 2023 Aug; 21():100698. PubMed ID: 37455816
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
Hidalgo-Ríos S; Carrillo-García J; Moura DS; Stacchiotti S; López-Pousa A; Redondo A; Italiano A; Gutiérrez A; Grignani G; Hindi N; López-Guerrero JA; Muro XGD; Trufero JM; Palmerini E; García AS; Bernabeu D; Le Cesne A; Casali PG; Blay JY; Cruz Jurado J; Martin-Broto J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077723
[TBL] [Abstract][Full Text] [Related]
4. Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk.
Sasamoto N; Babic A; Vitonis AF; Titus L; Cramer DW; Trabert B; Tworoger SS; Terry KL
Cancer Prev Res (Phila); 2021 Aug; 14(8):795-802. PubMed ID: 34244153
[TBL] [Abstract][Full Text] [Related]
5. Anaesthesia and cancer: can anaesthetic drugs modify gene expression?
Ponferrada AR; Orriach JLG; Manso AM; Haro ES; Molina SR; Heredia AF; Lopez MB; Mañas JC
Ecancermedicalscience; 2020; 14():1080. PubMed ID: 32863874
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms.
Dovnik A; Dovnik NF
Cells; 2020 Feb; 9(2):. PubMed ID: 32024052
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression correlates with development, progression, metastasis, and prognosis of osteosarcoma: a meta-analysis and trial sequential analysis.
Wang S; Gao H; Zuo J; Gao Z
FEBS Open Bio; 2019 Feb; 9(2):226-240. PubMed ID: 30761249
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature.
Pannunzio A; Coluccia M
Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30314310
[TBL] [Abstract][Full Text] [Related]
9. The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention.
Guo H; Guo J; Xie W; Yuan L; Sheng X
J Ovarian Res; 2018 Aug; 11(1):71. PubMed ID: 30157901
[TBL] [Abstract][Full Text] [Related]
10. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.
Beeghly-Fadiel A; Wilson AJ; Keene S; El Ramahi M; Xu S; Marnett LJ; Fadare O; Crispens MA; Khabele D
J Ovarian Res; 2018 Feb; 11(1):17. PubMed ID: 29482584
[TBL] [Abstract][Full Text] [Related]
11. COX-2 expression in ovarian cancer: an updated meta-analysis.
Sun H; Zhang X; Sun D; Jia X; Xu L; Qiao Y; Jin Y
Oncotarget; 2017 Oct; 8(50):88152-88162. PubMed ID: 29152148
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 sensitizes lung cancer cells to radiation-induced apoptosis.
Han ZQ; Liao H; Shi F; Chen XP; Hu HC; Tian MQ; Wang LH; Ying S
Oncol Lett; 2017 Nov; 14(5):5959-5965. PubMed ID: 29113232
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis.
Chen G; Li X; Yang J; Li J; Wang X; He J; Huang Z
Arch Med Sci; 2016 Oct; 12(5):1110-1117. PubMed ID: 27695503
[TBL] [Abstract][Full Text] [Related]
14. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.
Suri A; Sheng X; Schuler KM; Zhong Y; Han X; Jones HM; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Jun; 7(26):39582-39594. PubMed ID: 27074576
[TBL] [Abstract][Full Text] [Related]
15. Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.
Wilson AJ; Fadare O; Beeghly-Fadiel A; Son DS; Liu Q; Zhao S; Saskowski J; Uddin MJ; Daniel C; Crews B; Lehmann BD; Pietenpol JA; Crispens MA; Marnett LJ; Khabele D
Oncotarget; 2015 Aug; 6(25):21353-68. PubMed ID: 25972361
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells.
Guo FJ; Tian JY; Jin YM; Wang L; Yang RQ; Cui MH
Mol Med Rep; 2015 Jan; 11(1):59-66. PubMed ID: 25335121
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of GOLPH3 protein is associated with worse prognosis in patients with epithelial ovarian cancer.
Ma Y; Wang X; Wu Y; Sun B; Lv H; Rong F; Zheng X
Tumour Biol; 2014 Dec; 35(12):11845-9. PubMed ID: 25204671
[TBL] [Abstract][Full Text] [Related]
18. COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer.
Bhat IA; Rasool R; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Ganaie FA; Aziz SA; Shah ZA
Tumour Biol; 2014 Nov; 35(11):11209-18. PubMed ID: 25113252
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarkers in endometrial and ovarian carcinoma.
Matias-Guiu X; Davidson B
Virchows Arch; 2014 Mar; 464(3):315-31. PubMed ID: 24504546
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
